Wockhardt’s antibiotic Zaynich successfully treated a U.S. transplant patient with pan-drug-resistant infection, per a leading medical journal.

• Zaynich, a Zidebactam-Cefepime combo, cured a critically ill patient unresponsive to all U.S.-approved antibiotics.
• A case published in the Journal of Antimicrobial Chemotherapy highlights its potential for extremely drug-resistant infections.
• Over 50 patients globally treated under compassionate use; Phase III trial completed for global marketing approval.